In a groundbreaking move set to transform cancer diagnosis, Metropolis Healthcare Limited has joined forces with Singapore-based AI solutions provider, QritiveTM. This strategic partnership aims to redefine the landscape of cancer care through the integration of cutting-edge AI technology into pathology workflows.
Metropolis Healthcare, a pioneering diagnostic service provider in India, has long been committed to delivering precise and timely diagnosis. With the advent of AI, the potential to enhance diagnostic accuracy and efficiency has reached new heights. Through the adoption of Qritive’s AI platform, including the PantheonTM image management system, Metropolis aims to streamline cancer diagnosis processes, ensuring quality control and reducing turnaround times.
Mr. Surendran Chemmenkottil, CEO of Metropolis Healthcare Limited, emphasized the pivotal role of AI in modern healthcare, particularly in supporting pathologists and clinicians. He highlighted the potential for AI insights to expedite the diagnosis of various cancers, ultimately leading to more effective treatment decisions.
Dr. Kirti Chadha, Chief Scientific Officer & Senior Oncopathologist at Metropolis Healthcare, underscored the commitment to providing personalized cancer diagnoses for every patient. The integration of advanced AI technology empowers pathologists to deliver highly accurate results, facilitating swift prioritization of urgent cases and enhancing overall quality through AI-generated insights.
Clinical studies conducted by Qritive have demonstrated remarkable reductions in diagnosis time and discordance among pathologists, leading to heightened diagnostic accuracy and improved patient outcomes. Mr. Bruno Occhipinti, CEO of Qritive, expressed pride in the collaboration with Metropolis Healthcare, highlighting the transformative potential of AI in closing the gap in cancer care.
Qritive, as a leading AI solution developer, continues to advance digital pathology for cancer diagnosis, leveraging AI-based solutions to improve health outcomes and support clinicians in delivering quality care.
The collaboration between Metropolis Healthcare and Qritive marks a significant milestone in the integration of AI technology into pathology workflows, setting a new standard in cancer diagnostics and reaffirming the commitment to excellence in healthcare.